GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Contec Medical Systems Co Ltd (SZSE:300869) » Definitions » EBIT

Contec Medical Systems Co (SZSE:300869) EBIT : ¥26.9 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Contec Medical Systems Co EBIT?

Contec Medical Systems Co's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2024 was ¥33.6 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was ¥26.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Contec Medical Systems Co's annualized ROC % for the quarter that ended in Jun. 2024 was 0.08%. Contec Medical Systems Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 15.37%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Contec Medical Systems Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 0.56%.


Contec Medical Systems Co EBIT Historical Data

The historical data trend for Contec Medical Systems Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Contec Medical Systems Co EBIT Chart

Contec Medical Systems Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 81.95 717.89 410.86 238.47 231.23

Contec Medical Systems Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.75 -44.85 44.61 -6.49 33.58

Competitive Comparison of Contec Medical Systems Co's EBIT

For the Medical Devices subindustry, Contec Medical Systems Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Contec Medical Systems Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Contec Medical Systems Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Contec Medical Systems Co's EV-to-EBIT falls into.



Contec Medical Systems Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥26.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Contec Medical Systems Co  (SZSE:300869) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Contec Medical Systems Co's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=1.824 * ( 1 - 29.16% )/( (1602.242 + 1590.471)/ 2 )
=1.2921216/1596.3565
=0.08 %

where

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3098.265 - 52.807 - ( 1443.216 - max(0, 333.596 - 2150.686+1443.216))
=1602.242

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2834.827 - 44.04 - ( 1200.316 - max(0, 179.458 - 1869.207+1200.316))
=1590.471

Note: The Operating Income data used here is four times the quarterly (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Contec Medical Systems Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=134.332/( ( (289.245 + max(592.975, 0)) + (303.363 + max(562.547, 0)) )/ 2 )
=134.332/( ( 882.22 + 865.91 )/ 2 )
=134.332/874.065
=15.37 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(40.737 + 449.359 + 197.783) - (52.807 + 0 + 42.097)
=592.975

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(42.836 + 430.089 + 177.277) - (44.04 + 0 + 43.615)
=562.547

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Contec Medical Systems Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=26.855/4773.162
=0.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Contec Medical Systems Co EBIT Related Terms

Thank you for viewing the detailed overview of Contec Medical Systems Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Contec Medical Systems Co Business Description

Traded in Other Exchanges
N/A
Address
No. 112, Qinhuang West Street, Economic and Technological Development Zone, Hebei Province, Qinhuangdao, CHN, 066004
Contec Medical Systems Co Ltd is engaged in research and development, production and sales of medical diagnosis and monitoring equipment. The company's products portfolio includes Blood pressure series; Blood oxygen series; Multi-parameter monitoring series; In Vitro Diagnostic Series; EEG series; Breathing sleep series; ECG series; Digital Image Series; Fetal Monitoring Series; Arteriosclerosis Series; Telemedicine and health management; and Home health products.
Executives
Xu Yun Long Executives
Zheng Min Directors, Directors, and Executives
Yang Zhi Shan Directors, executives
Wang Gui Li Director
Liu Zhen Hong Executives
Kou Guo Zhi Executives
Gao Rui Bin Supervisors
Fu Chun Yuan Executives

Contec Medical Systems Co Headlines

No Headlines